Cruz AJ, Morín ZJ, Cruz MA, Tamayo FR, Taylor DT, Samiñón MM

Language: Spanish
References: 15
Page: 162-172
PDF size: 86.33 Kb.

ABSTRACT

Introduction: radiosynoviorthesis is used in treating chronic synovitis, a frequent complication of some systemic diseases as rheumatoid arthritis and hemophilia. There are different colloids and radioactive suspensions recommended in the international clinical practice, but the number is reduced and the availability limited.
Objective: obtaining and physical-chemical characterization of suspensions of chromium phosphate (III) labeled with several radionuclides as potential radiopharmaceuticals for using in radiosynoviorthesis.
Methods: the suspensions were obtained by chemical synthesis. Radionuclides were added at the beginning or after concluding the reaction. The particle size was estimated by means of optic microscopy and membrane filtration. Similarly, the stability of suspension when re-suspended in several media was evaluated by spectrophotometry. The radiochemical purity was determined by paper chromatography.
Results: a suspension of chromium (III) phosphate was obtained and characterized. It was found that the obtained product had a predominant particle size range of 0,8 to 5 μm and that when suspended in 2 % gelatin solution in 1mg/ml acetate buffer, it settled in no less than 3 hours. Technologies for the preparation of radiopharmaceuticals of Chromium (III) Phosphate labeled with 32P and 90Y were described. There was demonstrated the feasibility of labeling the obtained suspension with other trivalent radionuclides such as 177Lu and 68Ga.
Conclusions: the results allow considering the obtained Chromium (III) Phosphate suspension as a matrix for the preparation of radiopharmaceuticals to be used in radiosinoviorthesis aimed at various joints, depending on the physical and nuclear characteristics of the radionuclides.

REFERENCES

1. Siegel H, Luck JVJr, Siegel ME. Advances in Radionuclide Therapeutics in Orthopaedics. J Am Acad Orthop Surg. 2004;12(1):55-64.

2. Schneider P, Farahati J, Reiners C. Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia. J Nucl Med. 2005;46:48S-54S.

3. EANM. Procedure Guidelines for Radiosynovectomy. Eur J Nucl Med. 2003;30:BP7-BP11.

4. Dunn AL, Manco-Johnson M, Busch MT, Balark KL, Abshire TC. Leukemia and P32 Radionuclide Synovectomy for Hemophilic Arthropathy. J Thromb Haemost. 2005;3:1541-2.

5. Pandey U, Ketaki B, Grace S, Haladhar S, Pradeep Ch, Prem D, et al. Evaluation of 90Y Phosphate Particles as a Possible Radiation Synoviorthesis Agent. Nucl Med Commun. 2005;26(5):459-63.

6. Chakraborty S, Das T, Banerjee S, Haladhar DS, Venkatesh M. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun. 2006;27:661-8.

7. Prabhakar G, Satbir S, Sachdev, Umamaheswaria S, Sivaprasad N, Bhatiaa MH, et al. Development of samarium [32P] phosphate colloid for radiosynoviorthesis applications: Preparation, biological and preliminary clinical studies experience. Applied Radiation Isotopes. 2007;65:1309-13.

8. Melichar F, Kropacek M, Srank J, Beran M, Mirzajevova M, Zimova J, et al. Labelled compounds as radiopharmaceuticals for radiosynoviorthesis. J Radioanal Nucl Chem 2009;280(2):353-8.

9. Anguileri LJ. Rapid method for obtaining colloidal suspension of phosphorus-32 as chromic phosphate. 2nd. Int. Conf. On Peaceful Uses of Atomic Energy, UN, Geneva, Vol 20. 1958. p. 50-2.

10. Tarafdar A, Biswas S, Pramanik NK, Pramanik P. Synthesis of mesoporous chromium phosphate through an unconventional sol-gel route. Micropor. Mesopor Mater. 2006;89:204-8.

11. Image Tool. Last Update: Jun. 2006. [cited 2011 Jun 15] Available from: http://ddsdx.uthscsa.edu/dig/itdesc.html.

12. Arshady R. Microsphere, Microcapsule & Liposome. Radioladeled and Magnetic Particulates in Medicine y Biology. Vol. 3. Londres: Citus Books; 2001. p. 99.

13. Noble J, Jones AG, Davis MA, Sledge CB, Kramer RI, Livni E. Leakage of Radioactive Particle Systems from a Synovial Joint Studied with a Gamma Camera. Its Application to Radiation Synovectomy. J Bone Joint Surg Am. 1983;65(3):381-9.

14. Prabhakar G, Sachdev SS, Sivaprasad N. Radiation synovectomy (RS), an effective radiotherapy using radiopharmaceuticals for the treatment of inflammatory joint disorders. Pharma Times. 2009;41(6):11-4.

15. United State Pharmacopea. Chromic Phosphate P 32 Suspension. 30. ed. National Publishing: Philadelphia; 2007. p. 2945.